We got a number of important drugs from the Celgene acquisition, says Bristol Myers Squibb CEO

Pharma exec won't commit to selling life-saving drug in U.S. for lower price offered in Canada

Bristol Myers Squibb | Global Patient Week 2023: LinkedIn Live

Pharmaceutical CEOs testify before Senate panel on drug prices | full video

Chris Boerner shares his thoughts on A New Era of Leadership

Bristol Myers Squibb CEO: With KarXT we'll be able to deliver good accuracy without the side effects

Bristol-Myers CEO Says the Company Is in Transition